Myrobalan Therapeutics Holding, Inc. — Form D
Myrobalan Therapeutics Holding, Inc. of MEDFORD, MA, a company, filed a Form D exempt-offering notice with the SEC on 2024-01-24. The offering totals $24.0M, of which $24.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-01-24
- Form: D
- Accession: 0002009058-24-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $24.0M
- Amount sold: $24.0M
- Investors: 12
- Date of first sale: 2024-01-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-503241
Issuer
- Name: Myrobalan Therapeutics Holding, Inc.
- CIK: 0002009058
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 200 BOSTON AVENUE, SUITE G750, MEDFORD, MA, 02155
- Phone: 857-675-1485
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Guoping Feng | Director | MEDFORD, MA |
| Zhigang He | Director | MEDFORD, MA |
| Jing Yu Wang | Director | MEDFORD, MA |
| Shixiang Yan | Director | MEDFORD, MA |
| Minmin Yang | Director | MEDFORD, MA |
| Jing Yu Wang | Executive Officer | MEDFORD, MA |
More